Conference abstract
Conference abstract
Analysis of pancreatic cancer-infiltrating T-lymphocytes reveals that ENO-specific Tregs inhibit the effector T-cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cancer (PC) is an aggressive disease with dismal prognosis. Surgical resection is the recommended treatment for long-term survival, but patients with resectable PC are in the minority (with a 5-year survival rate of 20%). Therefore, development of novel therapeutic strategies, such as anti-PC immunotherapy, is crucial. α-Enolase (ENO1) is an enzyme expressed on the surface of pancreatic cancer cells and is able to promote cell migration and cancer metastasis. The capacity of ENO1 to induce an immune response in PC patients renders its true tumor-associated antigen. We have characterized the effector functions of ENO1-specific T cells isolated from PC patients, and we specifically evaluated the successful role of intratumoral T-helper 17 (Th17) cells and the inhibitory role of regulatory T (Tregs) cells in respectively promoting or reducing the cancer-specific immune response. For the first time we have demonstrated that ENO1-specific Th17 cells have a specific anticancer effector function in PC patients, and that there are decreased levels of these cells in cancer compared to healthy mucosa. Conversely, there are elevated levels of ENO1-specific Tregs in PC patients which lead to inhibition of the antigen-specific effector T cells, thus highlighting a possible role in promoting PC progression.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 30 Jan 2018
Inhibition of cancer cell immune evasion by combined application of cytotoxic T-lymphocytes and natural killer cells
Conference abstract · 2018
Immune activation profile of T cells from Colombian MSM with high-risk sexual behaviors and HIV-1 specific cytotoxic T-lymphocytes (CTL) response
Conference abstract · 28 Sep 2015
T-bet:Eomes balance, effector function and proliferation of CMV-specific CD8+ T-cells during primary infection differentiates the capacity for durable immune control
Conference abstract
Increased frequency of activated cytotoxic T-lymphocytes in HIV infected patients facilitate HIV associated dementia
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advancing Immune-Based Disease Management through Therapeutic Vaccines
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Amedeo Amedei”
